The Target: TRPV6
Mechanism of Action
Broad Patent Protection
Claims being pursued include composition claims as well as method claims providing us with the broadest protection.
Soricimed owns all the intellectual property surrounding the soricidin platform.
| | |
Peptide-Drug Conjugate Program
News and Events
18 Botsford St., Suite 201Moncton, N.B. E1C 4W7Canada
© Copyright 2019 Innovasium Soricimed Biopharma